CUSTOMER SUPPORT

4DMEDICAL

Latest News

Learn about 4DMedical’s latest developments and future projects as well—all aimed at significantly improving early detection, diagnosis, and therapeutic strategies for a range of pulmonary conditions, including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.
Veterans holding their lungs - color-mapped with XV LVAS®
15 July 2025

New Study Underscores XV Technology’s Power to Detect Hidden Lung Disease

A major new multi-center study published in Respiratory Research (July 2025) demonstrates that 4DMedical’s X-ray Velocimetry Lung Ventilation Analysis Software (XV LVAS®) can reveal early and subtle forms of small airways disease that are often missed by standard tests like spirometry and CT scans. Researchers from Vanderbilt University, Johns Hopkins,
READ MORE
XV LVAS - XV Scanner Bronchiectasis
11 July 2025

Innovative XV Technology Shows Promise for Detailed Lung Function Assessment in Bronchiectasis Patients

A new study led by UNSW Sydney researchers demonstrates the feasibility and promise of the innovative XV Scanner™ with XV LVAS®, non-invasive imaging tools developed by 4DMedical, for assessing regional lung function in adults with bronchiectasis caused by Primary Ciliary Dyskinesia (PCD) and other conditions.
READ MORE
Perfusion Education
27 June 2025

Understanding Lung Perfusion: What is it? Why does it matter? And how is it measured?

Early identification of Usual Interstitial Pneumonia (UIP) and diagnosis of Idiopathic Pulmonary Fibrosis (IPF) remains a significant challenge in pulmonary medicine. Despite advances in imaging and clinical awareness, the process still requires specialized training and experience that isn't always readily available—especially in non-urban or resource-limited healthcare settings. This gap can
READ MORE
Dr Chung Interview - AI for Early UIP Detection
17 June 2025

Addressing the Challenge of UIP—and IPF Diagnosis: A Conversation with Dr. Chung

Early identification of Usual Interstitial Pneumonia (UIP) and diagnosis of Idiopathic Pulmonary Fibrosis (IPF) remains a significant challenge in pulmonary medicine. Despite advances in imaging and clinical awareness, the process still requires specialized training and experience that isn't always readily available—especially in non-urban or resource-limited healthcare settings. This gap can
READ MORE
Olympus Announces Full Market Release of AI-Powered Emphysema Screening Program
09 June 2025

Olympus Launches Emphysema Screening Program Powered by 4DMedical, Expanding Early Diagnosis and Treatment Opportunities

A new peer-reviewed study published in Respiratory Research confirms that 4DMedical’s CT Lung Ventilation Analysis Software (CT LVAS) provides results comparable to those of the gold standard PET method, as well as two additional research techniques for assessing regional lung function. The findings demonstrate a strong association and agreement between
READ MORE
08 May 2025

August 14-16 | American Association for Bronchology and Interventional Pulmonology (AABIP) 2025 | Austin, Texas

AABIP 2025 represents a vibrant convergence of thought leaders and front‑line practitioners in advanced bronchoscopy, therapeutic airway procedures, and pleural disease management. Conference themes are thoughtfully structured into key tracks—Advanced Diagnostic Bronchoscopy, Airway‑based Therapeutics, Pleural Diseases, Medical Education, and a special focus on innovation, equity, and healthcare access—catering to a
READ MORE
OSIC Blog Post - Chuck Hatt
07 May 2025

Partner Spotlight: 4DMedical Featured by OSIC

We're thrilled to be featured in the latest OSIC Partner Spotlight, where Chuck Hatt, our Vice President of Medical & Clinical Affairs, discusses 4DMedical’s leadership in transforming pulmonary diagnostics. The blog highlights our commitment to advancing lung health through innovative, non-invasive imaging solutions powered by AI, including the FDA-cleared IQ-UIP™
READ MORE
03 May 2025

September 17-20 | PERT 2025 | San Diego, CA

4DMedical is excited to announce our participation in the 11th Annual Pulmonary Embolism (PE) Scientific Symposium, hosted by the PERT Consortium®, taking place September 17–20, 2025, in San Diego, California. This year’s event, held at the brand-new Gaylord Pacific Resort & Convention Center, promises to be a major gathering of
READ MORE
01 May 2025

October 19-22 | CHEST 2025 | Chicago, Illinois

From October 19–22, 2025, Chicago’s iconic McCormick Place will welcome thousands of pulmonary, critical care, and sleep medicine professionals for CHEST 2025. This landmark event, celebrating 90 years of leadership in chest medicine, promises four days of immersive learning, networking, and innovation.
READ MORE

What's new at 4DMedical

Get the latest news about respiratory imaging and ventilation analysis
CUSTOMER SUPPORT